EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Increased mortality in acromegaly is due to vascular and respiratory disease and is normalised by control of GH levels—A retrospective analysis from the UK Acromegaly Register 1970–2016

Steve Orme, Richard McNally, Peter W James, Jessica Davis, John Ayuk, Claire Higham, John Wass, UK Acromegaly Register Study Group

Clinical Endocrinology · 2024

DOI: 10.1111/cen.15060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Endocrinology, 2024. Verfasst von Steve Orme und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, St James's University Hospital Leeds, Leeds, UK. Hauptthemen laut MEDLINE: Acromegaly, Human Growth Hormone. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novartis Pharma, Ipsen Biopharmaceuticals, Leeds Hospital Charitable Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Epidemiological studies involving patients with acromegaly have yielded conflicting results regarding cancer incidence and causes of mortality in relation to control of growth hormone (GH) excess.

Objective

The objective of this retrospective cohort study is to clarify these questions and identify goals for treatment and monitoring patients.

Methods

We studied 1845 subjects from the UK Acromegaly Register (1970–2016), obtaining cancer standardised incidence rates (SIR) and all causes standardised mortality rates (SMR) from UK Office for National Statistics, to determine the relationship between causes of mortality—age at diagnosis, duration of disease, post‐treatment and mean GH levels.

Results

We found an increased incidence of all cancers (SIR, 1.38; 95% CI: 1.06–1.33, p < .001), but no increase in incidence of female breast, thyroid, colon cancer or any measure of cancer mortality. All‐cause mortality rates were increased (SMR, 1.35; 95% CI: 1.24–1.46, p < .001), as were those due to vascular and respiratory diseases. All‐cause, all cancer and cardiovascular deaths were highest in the first 5 years following diagnosis. We found a positive association between post‐treatment and mean treatment GH levels and all‐cause mortality ( p < .001 and p < .001), which normalised with posttreatment GH levels of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcromegalyHuman Growth HormoneAdultAgedFemaleHumansMaleMiddle AgedYoung AdultCardiovascular DiseasesIncidenceNeoplasmsRegistriesRespiratory Tract DiseasesRetrospective StudiesUnited KingdomVascular Diseases

Stichwörter der Autor:innen

UK Acromegaly Registercancer incidence ratescontrol of GH levelsmortality rates

Substanzen

Human Growth Hormone

Autor:innen und Institutionen

  • Department of Endocrinology, St James's University Hospital Leeds, Leeds, UK.
  • Population Health Science Institute, Newcastle University, Royal Victoria Infirmary, Newcastle Upon Tyne, UK.
  • Society for Endocrinology, Bristol, UK.
  • Department of Endocrinology, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK.
  • Department of Endocrinology, Christie Hospital NHS Foundation Trust, Division of Cancer Sciences, University of Manchester, Manchester, UK.
  • Department of Endocrinology, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, UK.

Förderung

  • Novartis Pharma
  • Ipsen Biopharmaceuticals
  • Leeds Hospital Charitable Foundation
  • Clinical Endocrinology Trust
  • Pfizer UK

Zitieren

APA

Orme, S., McNally, R., James, P. W., Davis, J., Ayuk, J., Higham, C., Wass, J., & UK Acromegaly Register Study Group (2024). Increased mortality in acromegaly is due to vascular and respiratory disease and is normalised by control of GH levels—A retrospective analysis from the UK Acromegaly Register 1970–2016. Clinical Endocrinology. https://doi.org/10.1111/cen.15060

Vancouver

Orme S, McNally R, James PW, Davis J, Ayuk J, Higham C, et al. Increased mortality in acromegaly is due to vascular and respiratory disease and is normalised by control of GH levels—A retrospective analysis from the UK Acromegaly Register 1970–2016. Clinical Endocrinology. 2024. doi:10.1111/cen.15060

BibTeX
@article{Orme2024,
  author = {Orme, Steve and McNally, Richard and James, Peter W and Davis, Jessica and Ayuk, John and Higham, Claire and Wass, John and UK Acromegaly Register Study Group, UK Acromegaly Register Study Group},
  title = {Increased mortality in acromegaly is due to vascular and respiratory disease and is normalised by control of GH levels—A retrospective analysis from the UK Acromegaly Register 1970–2016},
  journal = {Clinical Endocrinology},
  year = {2024},
  doi = {10.1111/cen.15060}
}
Kostenlos starten →